Lieberman JA and First MB: Psychotic disorders. N Engl J Med. 379:270–280. 2018.PubMed/NCBI View Article : Google Scholar

Zwicker A, Denovan-Wright EM and Uher R: Gene-environment interplay in the etiology of psychosis. Psychol Med. 48:1925–1936. 2018.PubMed/NCBI View Article : Google Scholar

Tsuang MT, Bar JL, Stone WS and Faraone SV: Gene-environment interactions in mental disorders. World Psychiatry. 3:73–83. 2004.PubMed/NCBI

Bell V, Wilkinson S, Greco M, Hendrie C, Mills B and Deeley Q: What is the functional/organic distinction actually doing in psychiatry and neurology? Wellcome Open Res. 5(138)2020.PubMed/NCBI View Article : Google Scholar

Strimbu K and Tavel JA: What are biomarkers? Curr Opin HIV AIDS. 5:463–466. 2010.PubMed/NCBI View Article : Google Scholar

Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, Brittain C, Rujescu D, Giegling I, Turck CW, et al: Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One. 5(e9166)2010.PubMed/NCBI View Article : Google Scholar

Rabinca AA, Buleandra M, Tache F, Mihailciuc C, Ciobanu AM, Stefanescu DC and Ciucu AA: Voltammetric method for simultaneous determination of L-Dopa and Benserazide. Curr Anal Chem. 13:218–224. 2017.

Patrascu DG, David V, Balan I, Ciobanu AM, David IG, Lazar P, Ciurea I, Stamatin I and Ciucu AA: Selective DPV method of dopamine determination in biological samples containing ascorbic acid. Anal Lett. 43:1100–1110. 2010.

Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, Owens SJ, Rothmond DA and Shannon Weickert C: Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia. Front Immunol. 11(2002)2020.PubMed/NCBI View Article : Google Scholar

Birnbaum R and Weinberger DR: A genetics perspective on the role of the (Neuro)Immune system in schizophrenia. Schizophr Res. 217:105–113. 2020.PubMed/NCBI View Article : Google Scholar

Herron JW, Nerurkar L and Cavanagh J: Neuroimmune biomarkers in mental Illness. Curr Top Behav Neurosci. 40:45–78. 2018.PubMed/NCBI View Article : Google Scholar

Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, Cairns M and Weickert CS: Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 18:206–214. 2013.PubMed/NCBI View Article : Google Scholar

Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA and Klein HC: Neuroinflammation in schizophrenia-related psychosis: A PET study. J Nucl Med. 50:1801–1807. 2009.PubMed/NCBI View Article : Google Scholar

Kurumaji A, Wakai T and Toru M: Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics. J Neural Transm. 104:1361–1370. 1997.PubMed/NCBI View Article : Google Scholar

Bergink V, Gibney SM and Drexhage HA: Autoimmunity, inflammation, and psychosis: A search for peripheral markers. Biol Psychiatry. 75:324–331. 2014.PubMed/NCBI View Article : Google Scholar

Maino K, Gruber R, Riedel M, Seitz N, Schwarz M and Müller N: T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res. 152:173–180. 2007.PubMed/NCBI View Article : Google Scholar

Modabbernia A, Taslimi S, Brietzke E and Ashrafi M: Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol Psychiatry. 74:15–25. 2013.PubMed/NCBI View Article : Google Scholar

Goldstein BI, Kemp DE, Soczynska JK and McIntyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature. J Clin Psychiatry. 70:1078–1090. 2009.PubMed/NCBI View Article : Google Scholar

Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P and Andreassen OA: Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. J Psychiatr Res. 45:1608–1616. 2011.PubMed/NCBI View Article : Google Scholar

Miller BJ, Buckley P, Seabolt W, Mellor A and Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry. 70:663–671. 2011.PubMed/NCBI View Article : Google Scholar

Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJ, McKenna PJ and Bahn S: Altered T-cell function in schizophrenia: A cellular model to investigate molecular disease mechanisms. PLoS One. 2(e692)2007.PubMed/NCBI View Article : Google Scholar

Dean B, Kulkarni J, Copolov DL, Shrikanthan P, Malone V and Hill C: Dopamine uptake by platelets from subjects with schizophrenia: A correlation with the delusional state of the patient. Psychiatry Res. 41:17–24. 1992.PubMed/NCBI View Article : Google Scholar

Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF and Williams KL: Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 13:19–50. 1996.PubMed/NCBI View Article : Google Scholar

Martins-de-Souza D, Guest PC, Rahmoune H and Bahn S: Proteomic approaches to unravel the complexity of schizophrenia. Expert Rev Proteomics. 9:97–108. 2012.PubMed/NCBI View Article : Google Scholar

Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, et al: Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med. 3(e428)2006.PubMed/NCBI View Article : Google Scholar

Shao X, Yan C, Sun D, Fu C, Tian C, Duan L and Zhu G: Association between glutathione peroxidase-1 (Gpx-1) polymorphisms and schizophrenia in the Chinese han population. Neuropsychiatr Dis Treat. 16:2297–2305. 2020.PubMed/NCBI View Article : Google Scholar

Tran TV, Dang DK, Tran HQ, Shin EJ, Jang CG, Yamada K, Nabeshima T and Kim HC: PM377. Role of glutathione peroxidase-1 gene in the phencyclidine-induced schizophrenia-like psychosis in mice. Int J Neuropsychopharmacol. 19(38)2016.

van Kammen DP, Peters J, Yao J, Neylan T, Beuger M, Pontius E and O'Connor DT: CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships. Schizophr Res. 6:31–39. 1991.PubMed/NCBI View Article : Google Scholar

Takahashi N, Ishihara R, Saito S, Maemo N, Aoyama N, Ji X, Miura H, Ikeda M, Iwata N, Suzuki T, et al: Association between chromogranin A gene polymorphism and schizophrenia in the Japanese population. Schizophr Res. 83:179–183. 2006.PubMed/NCBI View Article : Google Scholar

Lee SA and Huang KC: Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia. BMC Med Genomics. 9(68)2016.PubMed/NCBI View Article : Google Scholar

Anderson SA, Volk DW and Lewis DA: Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res. 19:111–119. 1996.PubMed/NCBI View Article : Google Scholar

Law AJ, Weickert CS, Hyde TM, Kleinman JE and Harrison PJ: Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines. Am J Psychiatry. 161:1848–1855. 2004.PubMed/NCBI View Article : Google Scholar

Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff G, Schmitt A, Bogerts B and Bernstein HG: Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J Biol Psychiatry. 11:556–566. 2010.PubMed/NCBI View Article : Google Scholar

Pongrac JL, Middleton FA, Peng L, Lewis DA, Levitt P and Mirnics K: Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry. 56:943–950. 2004.PubMed/NCBI View Article : Google Scholar

Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, et al: Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol Psychiatry. 13:162–172. 2008.PubMed/NCBI View Article : Google Scholar

Huang JT, Wang L, Prabakaran S, Wengenroth M, Lockstone HE, Koethe D, Gerth CW, Gross S, Schreiber D, Lilley K, et al: Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. Mol Psychiatry. 13:1118–1128. 2008.PubMed/NCBI View Article : Google Scholar

Boiko AS, Mednova IA, Kornetova EG, Semke AV, Bokhan NA, Loonen AJM and Ivanova SA: Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia. Heliyon. 5(e02033)2019.PubMed/NCBI View Article : Google Scholar

Famitafreshi H and Karimian M: Prostaglandins as the agents that modulate the course of brain disorders. Degener Neurol Neuromuscul Dis. 10:1–13. 2020.PubMed/NCBI View Article : Google Scholar

Condray R and Yao JK: Cognition, dopamine and bioactive lipids in schizophrenia. Front Biosci (Schol Ed). 3:298–330. 2011.PubMed/NCBI View Article : Google Scholar

Giusti L, Mantua V, Da Valle Y, Ciregia F, Ventroni T, Orsolini G, Donadio E, Giannaccini G, Mauri M, Cassano GB and Lucacchini A: Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: A proteomic approach. Mol Biosyst. 10:1246–1254. 2014.PubMed/NCBI View Article : Google Scholar

Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C and Jensen LJ: STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41 (Database Issue):D808–D815. 2013.PubMed/NCBI View Article : Google Scholar

de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS and Bahn S: Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res. 154:23–29. 2014.PubMed/NCBI View Article : Google Scholar

Buttarelli FR, Fanciulli A, Pellicano C and Pontieri FE: The dopaminergic system in peripheral blood lymphocytes: From physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr Neuropharmacol. 9:278–288. 2011.PubMed/NCBI View Article : Google Scholar

Perez-Costas E, Melendez-Ferro M, Rice MW, Conley RR and Roberts RC: Dopamine pathology in schizophrenia: Analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra. Front Psychiatry. 3(31)2012.PubMed/NCBI View Article : Google Scholar

Liu L, Jia F, Yuan G, Chen Z, Yao J, Li H and Fang C: Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis. Psychiatry Res. 176:1–7. 2010.PubMed/NCBI View Article : Google Scholar

Kessler A and Shinitzky M: Platelets from schizophrenic patients bear autoimmune antibodies that inhibit dopamine uptake. Psychobiology. 21:299–306. 1993.

Rabey JM, Lerner A, Sigal M, Graff E and Oberman Z: [3H]dopamine uptake by platelet storage granules in schizophrenia. Life Sci. 50:65–72. 1992.PubMed/NCBI View Article : Google Scholar

Arrúe A, Dávila R, Zumárraga M, Basterreche N, González-Torres MA, Goienetxea B, Zamalloa MI, Anguiano JB and Guimón J: GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients. Neurochem Res. 35:247–253. 2010.PubMed/NCBI View Article : Google Scholar

Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, et al: Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Mol Psychiatry. 19:228–234. 2014.PubMed/NCBI View Article : Google Scholar

Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J and Bernardo M: Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Psychiatry Res. 168:110–118. 2009.PubMed/NCBI View Article : Google Scholar

Sumiyoshi T, Kurachi M, Kurokawa K, Yotsutsuji T, Uehara T, Itoh H and Saitoh O: Plasma homovanillic acid in the prodromal phase of schizophrenia. Biol Psychiatry. 47:428–433. 2000.PubMed/NCBI View Article : Google Scholar

Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, et al: Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 15:3132–3145. 2006.PubMed/NCBI View Article : Google Scholar

Melas PA, Rogdaki M, Ösby U, Schalling M, Lavebratt C and Ekström TJ: Epigenetic aberrations in leukocytes of patients with schizophrenia: Association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J. 26:2712–2718. 2012.PubMed/NCBI View Article : Google Scholar

Cao T, Li N and Cai H: Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist? Schizophr Res. 226:95–110. 2020.PubMed/NCBI View Article : Google Scholar

Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB and Laruelle M: Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort. Am J Psychiatry. 155:761–767. 1998.PubMed/NCBI View Article : Google Scholar

Winton-Brown TT, Fusar-Poli P, Ungless MA and Howes OD: Dopaminergic basis of salience dysregulation in psychosis. Trends Neurosci. 37:85–94. 2014.PubMed/NCBI View Article : Google Scholar

Catak Z, Kocdemir E, Ugur K, Yardim M, Sahin İ, Kaya H and Aydin S: A novel biomarker renalase and its relationship with its substrates in schizophrenia. J Med Biochem. 38:299–305. 2019.PubMed/NCBI View Article : Google Scholar

Nagaoka S, Iwamoto N and Arai H: First-episode neuroleptic-free schizophrenics: Concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment. Biol Psychiatry. 41:857–864. 1997.PubMed/NCBI View Article : Google Scholar

Abi-Dargham A: Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol. 78:133–164. 2007.PubMed/NCBI View Article : Google Scholar

Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M and Muck-Seler D: Platelet serotonin and serum lipids in psychotic mania. J Affect Disord. 97:247–251. 2007.PubMed/NCBI View Article : Google Scholar

Altamura C, Guercetti G and Percudani M: Dexamethasone suppression test in positive and negative schizophrenia. Psychiatry Res. 30:69–75. 1989.PubMed/NCBI View Article : Google Scholar

Tandon R, Mazzara C, DeQuardo J, Craig KA, Meador-Woodruff JH, Goldman R and Greden JF: Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry. 29:953–964. 1991.PubMed/NCBI View Article : Google Scholar

Hubbard DB and Miller BJ: Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology. 104:269–275. 2019.PubMed/NCBI View Article : Google Scholar

van Rijn S, Aleman A, de Sonneville L, Sprong M, Ziermans T, Schothorst P, van Engeland H and Swaab H: Neuroendocrine markers of high risk for psychosis: Salivary testosterone in adolescent boys with prodromal symptoms. Psychol Med. 41:1815–1822. 2011.PubMed/NCBI View Article : Google Scholar

Lodha P and Karia S: Testosterone and Schizophrenia: A clinical review. Ann Indian Psychiatry. 3:92–96. 2019.

Shetti NP, Nayak DS, Reddy KR and Aminabhvi TM: Graphene Clay-based hybrid nanostructures for electrochemical sensors and biosensors. In: Graphene-Based Electrochemical Sensors for Biomolecules. Pandikumar A and Rameshkumar (eds.) Elsevier, New York, pp235-274, 2019.

Elugoke SE, Adekunle SA, Fayemi OE, Akpan ED, Mamba BB, El-Sayed MS and Ebenso EE: Molecularly imprinted polymers (MIPs) based electrochemical sensors for the determination of catecholamine neurotransmitters-Review. Electrochem Sci Adv. 1(e2000026)2021.

Gao LL and Gao EQ: Metal-organic frameworks for electrochemical sensors of neurotransmitters. Coord Chem Rev. 434(213784)2021.

Liu X and Liu Y: Biosensors and sensors for dopamine detection. VIEW. 2(20200102)2021.

Rusheen AE, Gee TA, Jang DP, Blaha CD, Bennet KE, Lee KH, Heien ML and Oh Y: Evaluation of electrochemical methods for tonic dopamine detection in vivo. Trends Analyt Chem. 132(116049)2020.PubMed/NCBI View Article : Google Scholar

Butler D, Moore D, Glavin NR, Robinson JA and Ebrahimi A: Facile Post-deposition annealing of graphene ink enables ultrasensitive electrochemical detection of dopamine. ACS Appl Mater Interfaces. 13:11185–11194. 2021.PubMed/NCBI View Article : Google Scholar

Chang AY, Liu X, Pei Y, Gong C, Arumugam PU and Wang S: Dopamine sensing with robust carbon nanotube implanted polymer micropillar array electrodes fabricated by coupling micromolding and infiltration coating processes. Electrochim Acta. 368(137632)2021.

Brycht M, Baluchová S, Taylor A, Mortet V, Sedláková S, Klimša L, Kopeček J and Schwarzová-Pecková K: Comparison of electrochemical performance of various boron-doped diamond electrodes: Dopamine sensing in biomimicking media used for cell cultivation. Bioelectrochemistry. 137(107646)2021.PubMed/NCBI View Article : Google Scholar

Arif N, Gul S, Sohail M, Rizwan S and Iqbal M: Synthesis and characterization of layered Nb2C MXene/ZnS nanocomposites for highly selective electrochemical sensing of dopamine. Ceram Int. 47:2388–2396. 2021.

Dong Y, Liu J and Zheng J: A sensitive dopamine electrochemical sensor based on hollow zeolitic imidazolate framework. Colloids Surf A Physicochem Eng Asp. 608(125617)2021.

Amiri M, Javar HA and Mahmoudi-Moghaddam H: Facile green synthesis of NiO/NiCo2O4 nanocomposite as an efficient electrochemical platform for determination of dopamine. Electroanalysis. 33:1205–1214. 2021.

Shafi PM, Joseph N, Karthik R, Shim JJ, Bose AC and Ganesh V: Lemon juice-assisted synthesis of LaMnO3 perovskite nanoparticles for electrochemical detection of dopamine. Microchem J. 164(105945)2021.

Morawski FM, Xavier BB, Virgili AH, Caetano KDS, de Menezes EW, Benvenutti EV, Costa TMH and Arenas LT: A novel electrochemical platform based on mesoporous silica/titania and gold nanoparticles for simultaneous determination of norepinephrine and dopamine. Mater Sci Eng C Mater Biol Appl. 120(111646)2021.PubMed/NCBI View Article : Google Scholar

Liu L, Ge Y, Liu X, Ruan J, Cao J, Wei C, Fang P, Zhou J, Ma J and Tong Z: One-pot ball-milling preparation of cetylpyridinium chloride/azirconium phosphate composite for simultaneous detection of ascorbic acid and dopamine. J Alloys Compd. 860(157927)2021.

Kokulnathan T, Ahmed F, Chen SM, Chen TW, Hasan PMZ, Bilgrami AL and Darwesh R: Rational confinement of yttrium vanadate within Three-dimensional graphene aerogel: Electrochemical analysis of monoamine neurotransmitter (Dopamine). ACS Appl Mater Interfaces. 13:10987–10995. 2021.PubMed/NCBI View Article : Google Scholar

Tian J and Wu W: A novel preparation of water-dispersed graphene and their application to electrochemical detection of dopamine. Adv Powder Technol. 32:619–629. 2021.

Anbumannan V, Kumar RTR and Suresh K: Enhanced electrochemical detection of dopamine by graphene oxide/tungsten trioxide nanocomposite. Mater Sci Semicond Process. 127(105696)2021.

Han G, Cai J, Liu C, Ren J and Wang X, Yang J and Wang X: Highly sensitive electrochemical sensor based on xylan-based Ag@CQDs-rGO nanocomposite for dopamine detection. Appl Surf Sci. 541(148566)2021.

Li R, Liang H, Zhu M, Lai M, Wang S, Zhang H, Ye H, Zhu R and Zhang W: Electrochemical dual signal sensing platform for the simultaneous determination of dopamine, uric acid and glucose based on copper and cerium bimetallic carbon nanocomposites. Bioelectrochemistry. 139(107745)2021.PubMed/NCBI View Article : Google Scholar

Guan Q, Guo H, Xue R, Wang M, Zhao X, Fan T and Yang W, Xu M and Yang W: Electrochemical sensor based on covalent organic frameworks-MWCNTNH2/AuNPs for simultaneous detection of dopamine and uric acid. J Electroanal Chem. 880(114932)2021.

Abdi MM, Azli NFWM, Chaibakhsh N, Lim HN, Tahir PM, Karimi G and Khorram M: Nonenzymatic dopamine biosensor based on tannin nanocomposite. J Polym Sci. 59:428–438. 2021.

Aryal KP and Jeong HK: Simultaneous determination of ascorbic acid, dopamine, and uric acid with polyaniline/hemin/reduced graphite oxide composite. Chem Phys Lett. 768(138405)2021.

Da Silva LV, dos Santos ND, de Almeida AKA, dos Santos DDER, Santos ACF, França MC, Lima DJP, Lima PR and Goulart MOF: A new electrochemical sensor based on oxidized capsaicin/multi-walled carbon nanotubes/glassy carbon electrode for the quantification of dopamine, epinephrine, and xanthurenic, ascorbic and uric acids. J Electroanal Chem. 881(114919)2021.

Paulraj P, Rajendran K, Sathamraja A and Kannaiyan P: Solid phase mechanochemical synthesis of Poly(o-anisidine) protected Silver nanoparticles for electrochemical dopamine sensor. Mater Today Commun. 26(102191)2021.

Kannan A, Manojkumar S and Radhakrishnan S: A Facile Fabrication of Poly-ethionine Film on Glassy Carbon electrode for simultaneous and sensitive detection of dopamine and paracetamol. Electroanalysis. 33:1175–1184. 2021.

Shukla RP, Aroosh M, Matzafi A and Ben-Yoav H: Partially functional electrode modifications for rapid detection of dopamine in urine. Adv Funct Mater. 31(2004146)2021.

Guan H, Liu B, Gong D, Peng B, Han B and Zhang N: Direct electrochemical enhanced detection of dopamine based on peroxidase-like activity of Fe₃O₄@Au composite nanoparticles. Microchem J. 164(105943)2021.

Howes O, McCutcheon R and Stone J: Glutamate and dopamine in schizophrenia: An update for the 21st century. J Psychopharmacol. 29:97–115. 2015.PubMed/NCBI View Article : Google Scholar

McCutcheon RA, Abi-Dargham A and Howes OD: Schizophrenia, dopamine and the striatum: From Biology to Symptoms. Trends Neurosci. 42:205–220. 2019.PubMed/NCBI View Article : Google Scholar

Kaczor AA, Targowska-Duda KM, Silva AG, Kondej M, Biała G and Castro M: N-(2-Hydroxyphenyl)-1-(3-(2-oxo-2,3-dihydro-1H-benzimidazol-1yl)propyl)piperidine-4-Carboxamide (D2AAK4), a Multi-target ligand of aminergic GPCRs, as a potential antipsychotic. Biomolecules. 10(349)2020.PubMed/NCBI View Article : Google Scholar

Bloomfield MAP, McCutcheon RA, Kempton M, Freeman TP and Howes O: The effects of psychosocial stress on dopaminergic function and the acute stress response. Elife. 8(e46797)2019.PubMed/NCBI View Article : Google Scholar

Jacobsen JPR, Medvedev IO and Caron MG: The 5-HT deficiency theory of depression: Perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse. Philos Trans R Soc Lond B Biol Sci. 367:2444–2459. 2012.PubMed/NCBI View Article : Google Scholar

Ciobanu AM, Rosca T, Vladescu CT, Tihoan C, Popa MC, Boer MC and Cergan R: Frontal epidural empyema (Pott's puffy tumor) associated with Mycoplasma and depression. Rom J Morphol Embryol. 55:1203–1207. 2014.PubMed/NCBI